Age Dependence of Audiometric Bone Conduction Threshold in Normal Hearing Subjects
NCT ID: NCT02493686
Last Updated: 2020-11-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1093 participants
OBSERVATIONAL
2014-09-30
2020-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
audiogram
hearing test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age related normal hearing threshold level with air conducted pure tone audiogram
Exclusion Criteria
20 Years
79 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rudolf Probst, Prof.
Role: STUDY_DIRECTOR
University Hospital Zurich, clinic othorhinolaryngology, 8091 Zurich
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PR_16_09_2014
Identifier Type: -
Identifier Source: org_study_id